| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Renovorx, Inc. (RNXT) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. RNXT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 798.5K | $724.2K | - | |
| Dir | 47.6K | $43.2K | - | |
| Dir | 47.6K | $43.2K | - | |
| Dir | 47.6K | $43.2K | - | |
| VP | 41.6K | $37.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Voll Mark | Chief Financial Officer | Buy | 97,200 | $0.00 | - | New | -8.0% | - | |
| Mar 20, 2026 | Bagai Shaun77 | Chief Executive Officer | Buy | 24,300 | $0.00 | - | +8.4% | -8.0% | - | |
| Mar 20, 2026 | Marton Laurence | Director | Buy | 9,720 | $0.00 | - | New | -8.0% | - | |
| Jan 21, 2026 | Agah Ramtin76 | Chief Medical Officer | Buy | 10,000 | $1.00 | $9,975.00 | +1.3% | - | - | |
| Dec 31, 2025 | Agah Ramtin76 | Chief Medical Officer | Buy | 9,795 | $0.86 | $8,423.70 | +1.3% | +20.2% | - | |
| Dec 30, 2025 | Agah Ramtin76 | Chief Medical Officer | Buy | 205 | $0.83 | $169.33 | - | +22.3% | - | |
| Dec 18, 2025 | Bagai Shaun77 | Chief Executive Officer | Buy | 5,000 | $0.90 | $4,506.50 | +1.5% | +14.4% | - | |
| Dec 17, 2025 | Bagai Shaun77 | Chief Executive Officer | Buy | 5,000 | $0.85 | $4,262.00 | +1.5% | +11.0% | - | |
| Dec 16, 2025 | Agah Ramtin76 | Chief Medical Officer | Buy | 12,000 | $0.85 | $10,200.00 | +1.6% | +15.5% | - | |
| Dec 5, 2025 | Agah Ramtin76 | Chief Medical Officer | Buy | 10,000 | $0.96 | $9,600.00 | +1.3% | -12.7% | - |